These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17404598)

  • 61. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.
    Li Y; Revalde JL; Reid G; Paxton JW
    Drug Metab Rev; 2010 Nov; 42(4):590-611. PubMed ID: 20433315
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ABC-transporters: implications on drug resistance from microorganisms to human cancers.
    Lage H
    Int J Antimicrob Agents; 2003 Sep; 22(3):188-99. PubMed ID: 13678820
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple drug resistance associated with function of ABC-transporters in diabetes mellitus: molecular mechanism and clinical relevance.
    Koehn J; Fountoulakis M; Krapfenbauer K
    Infect Disord Drug Targets; 2008 Jun; 8(2):109-18. PubMed ID: 18537706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical studies of ABC-transporters contribution to the multidrug resistance of breast cancer].
    Litvyakov NV; Tsyganov MM
    Vopr Onkol; 2016; 62(1):45-52. PubMed ID: 30444331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Influence of ABC-transporters on intracellular distribution of anticancer drugs and contribution of this index to multidrug resistance phenotype].
    Ravcheeva AB; Bogush EA; Bogush TA
    Antibiot Khimioter; 2005; 50(2-3):22-9. PubMed ID: 16308936
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ABC transporters as cancer drivers: Potential functions in cancer development.
    Domenichini A; Adamska A; Falasca M
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):52-60. PubMed ID: 30268729
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?
    Theile D; Wizgall P
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1621-1632. PubMed ID: 34236499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent Advances in the Studies of Molecular Mechanisms Regulating Multidrug Resistance in Cancer Cells.
    Stavrovskaya AA; Rybalkina EY
    Biochemistry (Mosc); 2018 Jul; 83(7):779-786. PubMed ID: 30200862
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overcoming Multidrug Resistance in Cancer Stem Cells.
    Moitra K
    Biomed Res Int; 2015; 2015():635745. PubMed ID: 26649310
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
    Moiseeva NI; Laletina LA; Fetisov TI; Makhmudova LF; Manikaylo AE; Fomina LY; Burov DA; Lesovaya EA; Bokhyan BY; Zinovieva VY; Vilkova AS; Mekheda LV; Kozlov NA; Scherbakov AM; Kirilin EM; Belitsky GA; Yakubovskaya MG; Kirsanov KI
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328603
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance.
    Muriithi W; Macharia LW; Heming CP; Echevarria JL; Nyachieo A; Filho PN; Neto VM
    Cancer Biol Med; 2020 May; 17(2):253-269. PubMed ID: 32587767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease.
    Mo W; Zhang JT
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1049-63. PubMed ID: 19637987
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance.
    Huang J; Ecker GF
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677553
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
    Lockhart AC; Tirona RG; Kim RB
    Mol Cancer Ther; 2003 Jul; 2(7):685-98. PubMed ID: 12883042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of UDP-glucuronosyltransferases and drug transporters in breast cancer drug resistance.
    Starlard-Davenport A; Lyn-Cook B; Beland FA; Pogribny IP
    Exp Oncol; 2010 Sep; 32(3):172-80. PubMed ID: 21403613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.
    van de Ven R; Oerlemans R; van der Heijden JW; Scheffer GL; de Gruijl TD; Jansen G; Scheper RJ
    J Leukoc Biol; 2009 Nov; 86(5):1075-87. PubMed ID: 19745159
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Response of heterogeneous cancer cells on targeted nanoparticles.
    Wang Y; Li Y; Wang D; Hong S; Wang J; Xie B; Zhang Q; Zhang X; Shen H; Xiao Q
    Nanomedicine; 2016 Oct; 12(7):2127-2137. PubMed ID: 27262932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanisms of drug resistance in colon cancer and its therapeutic strategies.
    Hu T; Li Z; Gao CY; Cho CH
    World J Gastroenterol; 2016 Aug; 22(30):6876-89. PubMed ID: 27570424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Looking back at multidrug resistance (MDR) research and ten mistakes to be avoided when writing about ABC transporters in MDR.
    Borst P
    FEBS Lett; 2020 Dec; 594(23):4001-4011. PubMed ID: 33111311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors?
    Hegedus C; Ozvegy-Laczka C; Szakács G; Sarkadi B
    Curr Cancer Drug Targets; 2009 May; 9(3):252-72. PubMed ID: 19442047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.